Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
0.6199
-0.0127 (-2.01%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $637.92 thousand as of October 2, 2026. Its market cap has decreased by -84.42% in one year.
Market Cap
637.92K
Enterprise Value
-3.65M
1-Year Change
-84.42%
Ranking
Category
Stock Price
$0.62
ChartMarket Cap Chart
Since February 26, 2019, Biodexa Pharmaceuticals's market cap has decreased from $102.08M to $637.92K, a decrease of -99.38%. That is a compound annual growth rate of -48.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 637.92K | -66.50% |
| Dec 31, 2025 | 1.90M | -19.05% |
| Dec 31, 2024 | 2.35M | -66.48% |
| Dec 29, 2023 | 7.02M | 78.13% |
| Dec 30, 2022 | 3.94M | -68.73% |
| Dec 31, 2021 | 12.60M | -43.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Artelo Biosciences | 2.02M |
| Jaguar Health | 1.90M |
| Virax Biolabs Group | 1.75M |
| Curis | 1.68M |
| Silexion Therapeutics | 1.45M |
| Bone Biologics | 1.31M |
| Decoy Therapeutics | 1.16M |
| CDT Equity | 1.11M |